Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2013
SK4 Ca2+ activated K+ channel is a critical player in cardiac pacemaker derived from human embryonic stem cellsDavid Weisbrod, Asher Peretz, Anna Ziskind, et al.
EMBO Molecular Medicine|February 22, 2017
SK4 K<sup>+</sup> channels are therapeutic targets for the treatment of cardiac arrhythmiasShiraz Haron-Khun, David Weisbrod, Hanna Bueno, et al.
Journal of Cardiovascular Pharmacology|April 23, 2015
TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in PigsAssaf Malka, David Meerkin, Yaron D Barac, et al.
International Journal of Molecular Sciences|September 9, 2022
Bioenergetic and Metabolic Impairments in Induced Pluripotent Stem Cell-Derived Cardiomyocytes Generated from Duchenne Muscular Dystrophy PatientsLubna Willi, Ifat Abramovich, Jonatan Fernandez-Garcia, et al.
Cardiovascular Research|March 17, 2005
Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytesNaama Zeevi-Levin, Yaron D Barac, Yotam Reisner, et al.
Circulation. Heart Failure|May 12, 2011
TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failureZaid A Abassi, Yaron D Barac, Sawa Kostin, et al.
British Journal of Pharmacology|February 18, 2011
The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusionOffir Ertracht, Esti Liani, Noa Bachner-Hinenzon, et al.
International Journal of Molecular Sciences|August 7, 2021
Investigating <i>LMNA</i>-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived CardiomyocytesYuval Shemer, Lucy N Mekies, Ronen Ben Jehuda, et al.
Pageof 8